Cargando…
In Search of Biomarkers for Autism Spectrum Disorder
Autism Spectrum Disorder (ASD) lacks validated measures of core social functions across development stages suitable for clinical trials. We assessed the concurrent validity between ASD clinical measures and putative biomarkers of core deficits, and their feasibility of implementation in human studie...
Autores principales: | Del Valle Rubido, Marta, McCracken, James T., Hollander, Eric, Shic, Frederick, Noeldeke, Jana, Boak, Lauren, Khwaja, Omar, Sadikhov, Shamil, Fontoura, Paulo, Umbricht, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282609/ https://www.ncbi.nlm.nih.gov/pubmed/30324656 http://dx.doi.org/10.1002/aur.2026 |
Ejemplares similares
-
Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger’s Versus Healthy Controls: A Cross-Sectional Analysis
por: Del Valle Rubido, Marta, et al.
Publicado: (2020) -
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
por: Umbricht, Daniel, et al.
Publicado: (2017) -
What’s missing in autism spectrum disorder motor assessments?
por: Wilson, Rujuta B., et al.
Publicado: (2018) -
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial
por: Sahni, Jayashree, et al.
Publicado: (2020) -
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
por: Jacob, Suma, et al.
Publicado: (2022)